Roger Moody has joined Clinical Genomics as chief financial officer. He will direct the firm's strategic and tactical financial operations. Moody had been CEO of GlySure, where he remains a director. Prior to that, he was CFO at Nanosphere; executive VP, managing director, and COO at Indegene; and CFO at Medsn before that firm was acquired by Indegene.
Counsyl has appointed Ann Rhoads to its board of directors. Rhoads is former executive vice president and CFO at pharmaceutical company Zogenix. Previously, she was CFO and senior vice president at Premier. She currently serves as a board member and chair of the audit committee at Globus Medical, a musculoskeletal company, and Evoke Pharma, a pharmaceutical company that focuses on gastrointestinal disease. Rhoads Is also a board member and chair of the compensation committee at ophthalmic laser company Iridex Corporation.
Rady Children's Institute for Genomic Medicine Scientific Advisory Board
The Rady Children's Institute for Genomic Medicine has named six individuals to its inaugural scientific advisory board. They are:
James Downing, president and CEO, St. Jude's Children's Research Hospital
Elizabeth Blackburn, president, Salk Institute for Biological Studies
George Church, professor, Wyss Institute at Harvard University
Cato Laurencin, university professor and distiguished professor, University of Connecticut
Thomas Insel, former director, National Institute of Mental Health at the National Institutes of Health; former director of mental health research, Verily Life Sciences; and currernt president, Mindstrong Health
Isaac Kohane, professor and chair of biomedical informatics, Harvard Medical School; and professor of pediatrics, Boston Children's Hospital
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.